Recombinant Subunit Vaccines against Primate Lentiviruses
- 20 March 1996
- journal article
- review article
- Published by Mary Ann Liebert Inc in AIDS Research and Human Retroviruses
- Vol. 12 (5) , 451-453
- https://doi.org/10.1089/aid.1996.12.451
Abstract
No abstract availableThis publication has 21 references indexed in Scilit:
- Human immunodeficiency virus type 1 neutralization is determined by epitope exposure on the gp120 oligomer.The Journal of Experimental Medicine, 1995
- Pathogenicity of Live, Attenuated SIV After Mucosal Infection of Neonatal MacaquesScience, 1995
- Measuring Vaccine-Induced HIV Neutralization: Report of a WorkshopAIDS Research and Human Retroviruses, 1994
- HIV-1 envelope-elicited neutralizing antibody titres correlate with protection and virus load in chimpanzeesVaccine, 1994
- Mutational Analysis of the Assembly Domain of the HIV-1 Envelope GlycoproteinAIDS Research and Human Retroviruses, 1993
- Protective Effects of a Live Attenuated SIV Vaccine with a Deletion in the nef GeneScience, 1992
- Protection of Macaques Against SIV Infection by Subunit Vaccines of SIV Envelope Glycoprotein gp160Science, 1992
- In Vitro Assays for Detecting Neutralizing and Fusion-Inhibiting Antibodies to SIVMAC251AIDS Research and Human Retroviruses, 1991
- Protection of chimpanzees from infection by HIV-1 after vaccination with recombinant glycoprotein gp120 but not gp160Nature, 1990
- HIV antibodies and vaccine designAIDS, 1989